Volume 28, Supplement—December 2022
SUPPLEMENT ISSUE
Surveillance
Determining Gaps in Publicly Shared SARS-CoV-2 Genomic Surveillance Data by Analysis of Global Submissions
Elizabeth C. Ohlsen
, Anthony W. Hawksworth, Kimberly Wong, Sarah Anne J. Guagliardo, James A. Fuller, Michelle L. Sloan, and Kevin O’Laughlin
, Anthony W. Hawksworth, Kimberly Wong, Sarah Anne J. Guagliardo, James A. Fuller, Michelle L. Sloan, and Kevin O’Laughlin
Table 1
Sequencing volume by population and detected SARS-CoV-2 infections and submission lag, World Bank income category, and WHO regions based on data from GISAID and GenBank, 2021*
| Category |
No. countries |
Total no. (%) sequences |
Sequences/
1 million population |
Sequences/100,000 SARS-CoV-2 reported infections |
Median lag time, d (IQR) |
|
|---|---|---|---|---|---|---|
| World Bank income category | ||||||
| Low | 24 | 6,612 (0.1) | 11 | 524 | 98 (61–148) | |
| Lower middle | 43 | 172,582 (2.6) | 52 | 352 | 71 (41–115) | |
| Upper middle | 50 | 350,309 (5.4) | 137 | 556 | 34 (19–65) | |
| High | 68 | 6,004,367 (91.9) | 5,040 | 5,547 | 20 (11–35) | |
| WHO Regional Office | ||||||
| Africa | 41 | 54,115 (0.8) | 47 | 987 | 55 (32–101) | |
| The Americas | 42 | 2,617,580 (40.1) | 2,611 | 3,512 | 27 (18–47) | |
| United States | 1 | 2,161,680 (82.6) | 6,493 | 5,477 | 24 (17–39) | |
| Non–United States | 41 | 455,900 (17.4) | 154 | 1,302 | 42 (28–84) | |
| Eastern Mediterranean | 20 | 12,264 (0.2) | 17 | 101 | 56 (21–135) | |
| Europe | 54 | 3,433,142 (52.5) | 3,767 | 4,066 | 14 (9–25) | |
| United Kingdom | 1 | 1,542,137 (45.9) | 25,200 | 14,505 | 10 (8–14) | |
| Non–United Kingdom | 53 | 1,891,005 (55.1) | 1,767 | 2,362 | 20 (13–34) | |
| South-East Asia | 9 | 139,846 (2.1) | 138 | 818 | 63 (37–108) | |
| Western Pacific | 19 | 276,923 (4.2) | 72 | 1,259 | 49 (29–72) |
|
*A total of 6,533,870 sequences were collected in 2021. Bold indicates significance (p<0.001 by χ2 test). GISAID, https://www.gisaid.org; IQR, interquartile range; WHO, World Health Organization.
Page created: August 12, 2022
Page updated: December 11, 2022
Page reviewed: December 11, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.